Hasegawa N, Miura T, Ishizaka A, Yamaguchi K, Ishii K
Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Int J Tuberc Lung Dis. 2002 May;6(5):447-53.
National Minami-Yokohama Hospital, Kanagawa, Japan.
To compare the performance of a liquid medium system using the Mycobacteria Growth Indicator Tube (MGIT) with that of the conventional Japanese culture system using egg-based Ogawa medium, equivalent to Lowenstein-Jensen medium, in cases with pulmonary tuberculosis on chemotherapy.
A single-centre prospective case study of 61 hospitalised patients from 1 May to 31 July 1998 on a standard 6-month regimen of anti-tuberculosis chemotherapy including isoniazid, rifampin, streptomycin or ethambutol, and pyrazinamide. Sputum cultures using both culture systems were performed bi-weekly up to week 16 of treatment, and were further monitored by MGIT alone at the end of chemotherapy and every 6 months after the end of chemotherapy up to 2 years.
The detection time by MGIT gradually became longer with the progression of chemotherapy. The recovery rate at weeks 2, 4, 6, 8, and 10 by MGIT were significantly higher (P < 0.05) than on the Ogawa slants. Although one case was microbiologically diagnosed as a relapse, using the more sensitive MGIT system did not increase the relapse rate.
The gradual prolongation of detection time with the progression of treatment and an attainment of negativity of sputum culture at 4 months after chemotherapy could be a useful intermediate marker to monitor the efficacy of treatment for patients with pulmonary tuberculosis by the MGIT system. Further evaluation is necessary to establish the utility of MGIT in monitoring the treatment process.
日本神奈川县南横滨国立医院。
比较使用分枝杆菌生长指示管(MGIT)的液体培养基系统与使用基于鸡蛋的小川培养基(等同于罗-琴培养基)的传统日本培养系统,在接受化疗的肺结核病例中的性能表现。
一项单中心前瞻性病例研究,研究对象为1998年5月1日至7月31日期间住院的61例患者,这些患者接受标准的6个月抗结核化疗方案,包括异烟肼、利福平、链霉素或乙胺丁醇以及吡嗪酰胺。在治疗的第16周前,每两周使用两种培养系统进行痰培养,并在化疗结束时以及化疗结束后每6个月(直至2年)仅通过MGIT进行进一步监测。
随着化疗的进行,MGIT的检测时间逐渐变长。MGIT在第2、4、6、8和10周的回收率显著高于小川斜面培养基(P < 0.05)。尽管有1例在微生物学上被诊断为复发,但使用更敏感的MGIT系统并未增加复发率。
随着治疗的进行检测时间逐渐延长,且化疗后4个月痰培养转阴,这可能是通过MGIT系统监测肺结核患者治疗效果的一个有用的中间指标。需要进一步评估以确定MGIT在监测治疗过程中的实用性。